acute pain management jpmc
TRANSCRIPT
-
8/12/2019 Acute Pain Management Jpmc
1/21
Acute Pain Management
-
8/12/2019 Acute Pain Management Jpmc
2/21
Pain
Pain is an unpleasant feeling that is
conveyed to the brain by sensory
neurons as a result of injury, disease or
emotional disorder
-
8/12/2019 Acute Pain Management Jpmc
3/21
Pain
Acute pain
Less than six months duration
Cause is usually known
Disappears when the injury heals
Chronic pain
More than six months durations
Persists after injury heals
Cause may or may not be known
IASP website, 2007
-
8/12/2019 Acute Pain Management Jpmc
4/21
Types of pain
Neuropathic (burning, tingling, pins and
needles sensation)
Psychogenic
Idiopathic
-
8/12/2019 Acute Pain Management Jpmc
5/21
Common types of acute pain
Type or source Definition Examples
Acute illness Pain associated with an
acute illness
Appendicitis, renal colic,
myocardial infarction
Prioperative (includes
postoperative)
Pain in a surgical
patient because of pre-
existing disease,
surgical procedure,
associated drains, chest
or NG tube
Head or neck surgery,
chest and chest wall,
abdominal, orthopedic
surgery
Post traumatic (major
trauma)
Generalised or
regionalised pain due to
major acute injury
Motor vehicle accident
-
8/12/2019 Acute Pain Management Jpmc
6/21
Common types of acute pain
Type or source Definition Example
Post traumatic (minor
injury)
Pain due to minor injury Sprain, laceration
Burns Pains due to thermal or
chemical burns
Fire, chemical exposure
Procedural Pain associated with a
diagnostic or
therapeutic medical
procedure
Bone marrow biopsy,
endoscopy, suturing
catheter and chest tube
placement,circumcision,
immunizationObstetrical Pain related to labour
and delivery
Child birth by vaginal
delivery or cesarean
section
-
8/12/2019 Acute Pain Management Jpmc
7/21
Pain pathways
Tissue injury activate nociceptors pain
impulse A-delta & C fibers dorsal horn
spinothalamic tract thalamus
cerebral cortex cerebellum
Mediators
Prostaglandin, bradykinin, substance P,
serotanin, histamine
-
8/12/2019 Acute Pain Management Jpmc
8/21
-
8/12/2019 Acute Pain Management Jpmc
9/21
Physiological effects of pain
Endocrine effects
Increased catabolichormones (glucagon, GH,vasopressin )
Decreased anabolichormones (insulin,
testosterone)
Haematologic effects
Increased plateletadhesiveness
hyper coagulability
Immune effects
Lymphopaenia
Leukocytosis
Musculo skeletal
muscle spasm, immobility,
increased risk of DVT
muscle wasting, prolonged
recovery
CNS
central sensitization,
chronic pain
Psychological
Anxiety, fear, sleep
deprivation, increased pain
Urinary effects
Urinary retention
-
8/12/2019 Acute Pain Management Jpmc
10/21
Non pharmacological
Transcutaneous nerve stimulation
Cognitive and behavioral therapy
Heat and cold
Physical and occupation therapy Rehabilitation
Progressive muscle relaxation
Psychotherapy
Massage, accupuncture and accupressure Exercise therapy
Lifestyle changes
-
8/12/2019 Acute Pain Management Jpmc
11/21
Multimodal analgesia
Drugs
Reduce doses of each analgesic
Synergistic / additive effects
Decrease severity of side effects of each
drug
Technique
Oral, I/M, I/V, S/C, per rectal, nerve block,
plexus block, epidural block
-
8/12/2019 Acute Pain Management Jpmc
12/21
Treatment
Pharmacologic
Opioid
Non opioid
Adjuvant
-
8/12/2019 Acute Pain Management Jpmc
13/21
Pain management guideline
Pain symptom
intensity
Drug selection
Constant moderate tosevere pain
Intermittent pain
Long acting analgesics +prnshort acting analgesics
prn short actinganalgesics
Mild
Moderate
severe
-
8/12/2019 Acute Pain Management Jpmc
14/21
Multimodal analgesia
-
8/12/2019 Acute Pain Management Jpmc
15/21
Non opioids
Acetaminophen
Local anesthetic drugs
Nonsteroidal anti-inflammatory drugs
steroids
No physical dependence
No tolerance
-
8/12/2019 Acute Pain Management Jpmc
16/21
Acetaminophen
Effective analgesic
Action
Analgesic
Antipyretic
Anti-inflammatory agent
Relative safety
Effective for the musculoskeletal aches,
joint stiffness
-
8/12/2019 Acute Pain Management Jpmc
17/21
Acetaminophen
Disadvantage
Dose-dependent hepatotoxicity, GI upset
Agranulocytosis
Dosage
650-1000 mg PO q 4 hr.
Max. 4 g/d
Reduce dose 50-70%in patient with
significant hepatic impairment
-
8/12/2019 Acute Pain Management Jpmc
18/21
-
8/12/2019 Acute Pain Management Jpmc
19/21
-
8/12/2019 Acute Pain Management Jpmc
20/21
NSAID
Drug Dosage Maximum daily
dose
Nonselective
inhibitor
Diclofenac
Indomethacin
Ibuprofen
50 mg PO bid-tid
75 mg PO bid
200-800 mg q 6
hr.
200 mg
150 mg
3200 mg
Cox-2 inhibitor
Celecoxib 100-200 mg PO
bid
400 mg
-
8/12/2019 Acute Pain Management Jpmc
21/21
Thank you